By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


CogState Ltd 

21 Victoria Street, Level 7

Melbourne  Victoria  3000  Australia
Phone: 613-9664-1300 Fax: 613-9664-1301



Company News
CogState Ltd (CGS.AX) IPad Cognitive Assessments Selected For Use In Phase IV Observational Study Of Approved Treatments For Prostate Cancer 11/18/2015 7:59:27 AM
CogState Ltd (CGS.AX) Releases Latest Version Of Online Cognitive Screening Solution For Clinical Trials: Precision Recruitment 7/22/2015 1:25:45 PM
CogState Ltd (CGS.AX) Release: Computerized Cognition Test Provides Better Assessment than Observation 8/25/2014 8:06:59 AM
CogState Ltd (CGS.AX) Release: Early Detection Of Alzheimer's Disease Enables Caregivers To Significantly Delay Admission Of Their Loved Ones To Nursing Homes 4/9/2014 10:06:43 AM
CogState Ltd (CGS.AX)'s Technology Chosen For Major Phase 3 Trial Of Alzheimer's Disease Drug 3/25/2014 8:53:49 AM
US Strategic Investors Commit A$3.5 Million To Drive Global Business Growth For CogState Ltd (CGS.AX) 11/19/2013 9:28:37 AM
CogState Ltd (CGS.AX) and Merck & Co., Inc. (MRK) Launch COGNIGRAM™ to Physicians in Canada 3/6/2013 11:23:26 AM
CogState Ltd (CGS.AX) Signs Licensing Deal With Merck Canada 6/25/2012 7:25:11 AM
United BioSource Corporation and CogState Ltd (CGS.AX) Form Strategic Partnership to Support Cognitive Assessment in Clinical Research 8/5/2008 11:27:16 AM
CogState Ltd (CGS.AX) Issued US Patent 1/16/2007 3:55:55 PM